Also known as Bremelanotide, PT-141 is an FDA-approved peptide for sexual dysfunction. It works centrally in the brain rather than on the vascular system like traditional treatments.
Role: Supports hormones
Full peptide profile All stacksHormones 
The Sexual Health Stack
PT-141 (Bremelanotide) is FDA-approved for hypoactive sexual desire disorder in premenopausal women and has been researched for male sexual dysfunction. It works centrally — in the brain — rather than vascularly like PDE5 inhibitors, making it effective for people who do not respond to Viagra-class medications. It activates MC4 receptors in the brain to stimulate sexual desire and arousal. Gonadorelin supports the underlying hormonal environment by maintaining natural LH and FSH production, which drives testosterone and estrogen levels. Together they address sexual health from both the neurological desire pathway (PT-141) and the hormonal substrate that supports it (Gonadorelin). This combination is particularly interesting for research into sexual dysfunction that does not respond to conventional approaches.
🐾 Griffin Says...
PT-141 works in the brain, not in the blood vessels — that is the important distinction from conventional sexual health medications. Gonadorelin keeps the hormonal environment healthy, which matters because sexual function depends heavily on baseline hormone levels. FDA approval for PT-141 in HSDD gives this stack a meaningful evidence base.
Peptides in this stack
A synthetic version of GnRH that stimulates the release of LH and FSH. Used in research for testosterone support, fertility, and hormonal regulation.
Role: Supports hormones
Full peptide profileFor research purposes only. Nothing on this page is medical advice or a recommendation to use these compounds. Always consult a qualified professional before making health decisions.
Want to go deeper on these?
Join the community and swap notes with other researchers. 🐾
$9/month or $90/year